Mutual Advisors LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,919 shares of the exchange traded fund’s stock after selling 761 shares during the period. Mutual Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,487,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Tidemark LLC lifted its holdings in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth $44,000. Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth $49,000. Finally, Waldron Private Wealth LLC purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth $54,000.
SPDR S&P Biotech ETF Stock Down 0.6 %
SPDR S&P Biotech ETF stock opened at $92.46 on Friday. The business has a fifty day moving average of $93.34 and a two-hundred day moving average of $96.88. The firm has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Calculate Inflation Rate
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Compound Interest and Why It Matters When Investing
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Calculate Return on Investment (ROI)
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.